Published by Iain Gilbert on 10th December 2024
(Sharecast News) - Analysts at RBC Capital Markets upgraded Hikma Pharmaceuticals from 'sector perform' to 'outperform' on Tuesday as it took a look at the wider European pharmaceutical and biotechnology sector.
URL: http://www.digitallook.com/dl/news/story/34744909/...